E-ISSN 2063-5346
 
2022, Vol: 11, Issue: 4
11/4Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Research Article 


CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES

Dr. Raju Kamaraj, T.Sudheer Kumar.

Abstract
Indian manufacturing plants manufacturing for the United States should comply with the regulations of USFDA,
Indian Pharmaceutical Industries are the major suppliers of generic drugs to the US Market. USFDA has the right to inspect
manufacturing plants periodically to ensure manufacturing site compliance with the regulations. USFDA inspectors may issue
form483 about their findings and unjustified observations may turn into Warning letters. Investigation failures and Insufficient
corrective actions to Customer complaints, OOS and Deviations are grabbing more attention from USFDA auditors during
their manufacturing site inspection and these observations were turning into form 483 and Warning letters for Indian
Pharmaceutical Industries. A cross-sectional analysis was performed for the warning letters issued from 2010 to 2021 and all
Warning letters issued from Indian Pharmaceutical Industries during the study period and the Data has collected from UDFDA
publically accessible database. About 114 USFDA issued Indian Pharmaceutical industries warning letters 211 CFR citations
& 595 observations were analysed and categorised based on the violation theme. Insufficient Corrective actions of Out of
specifications, Consumer / Market complaint and deviation marks the primary reason for the issue of warning letters under
cGMP non-compliance violation.

Key words: CAPA, Deviation, Out of Specification, Customer Complaint, USFDA.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Dr. Raju Kamaraj
Articles by T.Sudheer Kumar
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Dr. Raju Kamaraj, T.Sudheer Kumar. CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. ECB. 2022; 11(4): 50-54. doi:10.31838/ecb/2022.11.04.007

Web Style

Dr. Raju Kamaraj, T.Sudheer Kumar. CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. https://www.eurchembull.com/?mno=96516 [Access: August 09, 2022]. doi:10.31838/ecb/2022.11.04.007

AMA (American Medical Association) Style

Dr. Raju Kamaraj, T.Sudheer Kumar. CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. ECB. 2022; 11(4): 50-54. doi:10.31838/ecb/2022.11.04.007


Vancouver/ICMJE Style

Dr. Raju Kamaraj, T.Sudheer Kumar. CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. ECB. (2022), [cited August 09, 2022]; 11(4): 50-54. doi:10.31838/ecb/2022.11.04.007


Harvard Style

Dr. Raju Kamaraj, T.Sudheer Kumar (2022) CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. ECB, 11 (4), 50-54. doi:10.31838/ecb/2022.11.04.007


Turabian Style

Dr. Raju Kamaraj, T.Sudheer Kumar. 2022. CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. European Chemical Bulletin, 11 (4), 50-54. doi:10.31838/ecb/2022.11.04.007


Chicago Style

Dr. Raju Kamaraj, T.Sudheer Kumar. "CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES." European Chemical Bulletin 11 (2022), 50-54. doi:10.31838/ecb/2022.11.04.007


MLA (The Modern Language Association) Style

Dr. Raju Kamaraj, T.Sudheer Kumar. "CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES." European Chemical Bulletin 11.4 (2022), 50-54. Print. doi:10.31838/ecb/2022.11.04.007


APA (American Psychological Association) Style

Dr. Raju Kamaraj, T.Sudheer Kumar (2022) CROSS-SECTIONAL ANALYSIS OF INVESTIGATION FAILURES CITED IN USFDA WARNING LETTERS AND ITS IMPACT ON INDIAN PHARMACEUTICAL INDUSTRIES. European Chemical Bulletin, 11 (4), 50-54. doi:10.31838/ecb/2022.11.04.007


Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights) Privacy Policy Publication Ethics and Publication Malpractice Statement Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The articles in European Chemical Bulletin are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Copyright © 2022 European Chemical Bulletin All Rights Reserved. Subject to change without notice from or liability to European Chemical Bulletin.
For best results, please use Internet Explorer or Google Chrome

Contact Information


European Chemical Bulletin

Budapest, Near Széchenyi István tér,

1051 Hungary

Email : editor@eurchembull.com